PURAPHARM CORPORATION LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 1498 for the last semiannual is 211.78 M HKD, and it's 8.56% higher compared to the previous semiannual. The net income of H2 23 is -68.41 M HKD.